Skip to main content
. Author manuscript; available in PMC: 2020 Jul 21.
Published in final edited form as: J Mol Biol. 2017 Feb 21;429(7):1030–1044. doi: 10.1016/j.jmb.2017.02.010

Fig. 2.

Fig. 2.

TcdA constructs used in this study and binding of actoxumab by Western blotting. (a) Domain organization of TcdA showing the CROP domain with LRs and SRs highlighted. The CROP fragment constructs (A0, A1, A2, A3, A4, and A5) used in this study are also shown. (b) Western blot of TcdA and TcdB holotoxins and of constructs A0, A2, A3, A4, B2, and B3.